It is becoming apparent that myogenesis is controlled, at least in part, by proteins that bind to DNA regulatory elements in muscle-specific genes. This research will investigate a minimal, muscle-specific DNA regulatory element to understand how gene expression is controlled by complex protein DNA-interactions. A 28 bp fragment of the skeletal actin promoter is sufficient for muscle-specific expression when it is placed upstream of a nonmuscle TATA element. This muscle regulatory element (MRE) contains the core sequence motif, CC(A/T)6GG, which is referred to as CArG. The MRE is functionally different from nonmuscle elements, such as the c-fos SRE, yet they share the CC(A/T)6GG motif and bind to the same subset of nuclear factors. Presumably sequence differences between these elements alter the factor binding properties and this contributes to the different expression properties of the cognate promoters. The proteins that bind to the skeletal actin MRE are MAPF1 (and 2), SRF, and a recently identified factor, MF3. We have purified the MF3 binding activity to homogeneity from muscle. Molecular clones for MF3 and MAPF1 will be isolated. This will be accomplished by screening expression libraries with binding site probes or by screening with degenerate oligonucleotides designed from peptide sequence data. The analysis of these clones will provide clues about the nature of the heterogeneity found with the MAPF1 and 2 and the MF3 polypeptides. Transcript level measurements will indicate whether the factors are themselves regulated by muscle-specific promoters. Molecular clones will enable the production of recombinant factors and allow a genetic analysis of factor function. Purified factors will also be used to initiate studies on the assembly of the nucleoprotein complex. Experiments will be performed to evaluate whether these factors form higher-order complexes or compete for binding to the MRE. We are constructing a series of chimeric DNA elements to elucidate the molecular basis for the functional differences between the MRE and the SRE. Analyses of expression and factor binding properties of the synthetic elements will provide insights about the structural requirements for muscle-specific expression.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR040197-02
Application #
3160521
Study Section
Molecular Cytology Study Section (CTY)
Project Start
1991-01-15
Project End
1994-12-31
Budget Start
1992-01-01
Budget End
1992-12-31
Support Year
2
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Case Western Reserve University
Department
Type
Schools of Medicine
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Ouchi, Noriyuki; Walsh, Kenneth (2007) Adiponectin as an anti-inflammatory factor. Clin Chim Acta 380:24-30
Galasso, Gennaro; Schiekofer, Stephan; Sato, Kaori et al. (2006) Impaired angiogenesis in glutathione peroxidase-1-deficient mice is associated with endothelial progenitor cell dysfunction. Circ Res 98:254-61
Schiekofer, Stephan; Shiojima, Ichiro; Sato, Kaori et al. (2006) Microarray analysis of Akt1 activation in transgenic mouse hearts reveals transcript expression profiles associated with compensatory hypertrophy and failure. Physiol Genomics 27:156-70
Ouchi, Noriyuki; Shibata, Rei; Walsh, Kenneth (2006) Cardioprotection by adiponectin. Trends Cardiovasc Med 16:141-6
Aprahamian, Tamar; Bonegio, Ramon; Rizzo, Jennifer et al. (2006) Simvastatin treatment ameliorates autoimmune disease associated with accelerated atherosclerosis in a murine lupus model. J Immunol 177:3028-34
Ouchi, Noriyuki; Shibata, Rei; Walsh, Kenneth (2006) Targeting adiponectin for cardioprotection. Expert Opin Ther Targets 10:573-81
Schiekofer, Stephan; Galasso, Gennaro; Sato, Kaori et al. (2005) Impaired revascularization in a mouse model of type 2 diabetes is associated with dysregulation of a complex angiogenic-regulatory network. Arterioscler Thromb Vasc Biol 25:1603-9
Shibata, Rei; Sato, Kaori; Pimentel, David R et al. (2005) Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms. Nat Med 11:1096-103
Shibata, Rei; Ouchi, Noriyuki; Ito, Masahiro et al. (2004) Adiponectin-mediated modulation of hypertrophic signals in the heart. Nat Med 10:1384-9
Mogi, Masaki; Yang, Jiang; Lambert, Jean-Francois et al. (2003) Akt signaling regulates side population cell phenotype via Bcrp1 translocation. J Biol Chem 278:39068-75

Showing the most recent 10 out of 27 publications